These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 6364459

  • 1. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
    Ojala A, Nikkanen VN, Paloheimo S, Palojoki A, Thölix E.
    Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma.
    Whitehead RP, Rosenbaum PR, Carbone PP.
    Cancer Treat Rep; 1984 May; 68(5):771-3. PubMed ID: 6539171
    [Abstract] [Full Text] [Related]

  • 3. Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.
    Vogelzang NJ, Trowbridge RC, Frenning DH, Theologides A, Kennedy BJ, Kelly DR, Ewing SL, Vosika GJ.
    Cancer Treat Rep; 1980 May; 64(8-9):997-1000. PubMed ID: 6256076
    [Abstract] [Full Text] [Related]

  • 4. [Combination chemotherapy for bronchogenic carcinoma based on cell type].
    Ohta M, Hara N, Ichikawa Y, Kanda T, Shima K, Hokama M.
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):86-94. PubMed ID: 2417564
    [Abstract] [Full Text] [Related]

  • 5. A phase II clinical trial evaluating the use of two sequential, four-drug combination chemotherapy regimens in ambulatory bronchogenic adenocarcinoma patients.
    Broder LE, Sridhar KS, Selawry OS, Charyulu KN, Rao RK, Saldana MJ, Lenz C.
    Am J Clin Oncol; 1992 Dec; 15(6):480-6. PubMed ID: 1449109
    [Abstract] [Full Text] [Related]

  • 6. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: cyclophosphamide, doxorubicin, and etoposide versus mitomycin and vinblastine (EST 2575, generation IV).
    Ruckdeschel JC, Day R, Weissman CH, Stolbach LL, Creech RH.
    Cancer Treat Rep; 1984 Nov; 68(11):1325-9. PubMed ID: 6388831
    [Abstract] [Full Text] [Related]

  • 7. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S.
    Arch Geschwulstforsch; 1985 Nov; 55(1):63-71. PubMed ID: 2985017
    [Abstract] [Full Text] [Related]

  • 8. [Therapeutic results in small-cell bronchial carcinoma after ACO II chemotherapy and adjuvant radiation].
    Leipner N, Harder T, Hövelmann B, Schüller H, Hartlapp JH, Boldt I.
    Strahlenther Onkol; 1987 Oct; 163(10):637-42. PubMed ID: 2823403
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of the results of chemotherapy in squamous cell bronchial carcinoma].
    Nagorni-Obradović L.
    Med Pregl; 1991 Oct; 44(9-10):387-90. PubMed ID: 1806789
    [Abstract] [Full Text] [Related]

  • 10. Combination chemotherapy in inoperable lung cancer--a trial of 2 regimens.
    Behera D, Malik SK.
    Indian J Chest Dis Allied Sci; 1989 Oct; 31(1):21-4. PubMed ID: 2509339
    [Abstract] [Full Text] [Related]

  • 11. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, generation III, HAM versus CAMP.
    Ruckdeschel JC, Mehta CR, Salazar OM, Creech RH, Sponzo RW.
    Cancer Treat Rep; 1981 Oct; 65(11-12):959-63. PubMed ID: 6794909
    [Abstract] [Full Text] [Related]

  • 12. [Value of polychemotherapy for bronchogenic carcinoma other than undifferentiated small cell carcinoma].
    Laberge F, Desmeules M, Bergeron D, La Forge J, Cormier Y.
    Union Med Can; 1984 Mar; 113(3):222-4. PubMed ID: 6730096
    [No Abstract] [Full Text] [Related]

  • 13. The impact of chemotherapy on small cell carcinoma of the bronchus.
    Smyth JF, Fowlie SM, Gregor A, Crompton GK, Busuttil A, Leonard RC, Grant IW.
    Q J Med; 1986 Oct; 61(234):969-76. PubMed ID: 2819933
    [Abstract] [Full Text] [Related]

  • 14. [MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial].
    Salvati F, Pallotta G, Antilli A, Nunziati F, De Marinis F, Lucchesi M.
    G Ital Chemioter; 1984 Oct; 31(1-2):185-9. PubMed ID: 6088341
    [No Abstract] [Full Text] [Related]

  • 15. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Aamdal S, Norwegian Lung Cancer Study Group.
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [Abstract] [Full Text] [Related]

  • 16. Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.
    Athanassiades P, Lagoudis M, Kostis E.
    J Chemother; 1989 Jul; 1(4 Suppl):1205-6. PubMed ID: 16312835
    [No Abstract] [Full Text] [Related]

  • 17. Intensive chemotherapy of small cell bronchogenic carcinoma.
    Cohen MH, Creaven PJ, Fossieck BE, Broder LE, Selawry OS, Johnston AV, Williams CL, Minna JD.
    Cancer Treat Rep; 1977 Jul; 61(3):349-54. PubMed ID: 194691
    [Abstract] [Full Text] [Related]

  • 18. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
    Evans WK, Feld R, DeBoer G, Osoba D, Curtis JE, Baker MA, Myers RE, Quirt IC, Pritchard KI, Brown TC, Kutas GJ, Blackstein ME, Ottema B, Millband L.
    Cancer Treat Rep; 1981 Jul; 65(11-12):947-54. PubMed ID: 7028256
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of 2 regimens of chemotherapy of small cell carcinoma of the lung: modified Hansen method and the ACOM method].
    Jassem J, Karnicka-Młodkowska H, Mierzewski P, Decker E, Krawczyk K, Lisowska B, Malak K, Słupek A, Sokół A, Sosnowski K.
    Pneumonol Pol; 1988 Apr; 56(4):142-51. PubMed ID: 2842737
    [No Abstract] [Full Text] [Related]

  • 20. Effects of amphotericin B with combination chemotherapy on response rates and on survival in non-small cell carcinoma of the lung.
    Presant CA, Metter GE, Multhauf P, Bertrand M, Chang FF, Klein L, Rappaport D, Kendregan B, Mackie A.
    Cancer Treat Rep; 1984 Apr; 68(4):651-4. PubMed ID: 6201270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.